Case File
efta-efta00708817DOJ Data Set 9OtherFrom: "Barrett, Paul S"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00708817
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Barrett, Paul S"
To: jeffrey epstein <jeevacation®gmail.com>
CC: "Giuffrida, David .1"
Subject: To Do - NRG bonds - reiterate OW
Date: Fri, 17 Feb 2012 18:52:51 +0000
Attachments: Short_Circuit.pdf
Jeffrey
We should buy $1mm of this bond. Ytw 7.625%.
Dave Katz reiterates OW in his initiation of a high yield utility monthly.
We reiterate our Overweight on NRG credit and update our NRG financial model in advance of earnings. We estimate that the
company generated $384 million of EBITDA in 4Q1 I. We expect NRG will address the lower natural gas price environment and how it
will impact, if at all, its timeline to refinance the 2017 notes and the company's shareholder friendly actions (i.e., dividends and
share repurchases). We model a pick-up in shareholder friendly activities; this assumption may prove conservative if the company does
not refinance the 2017 notes and given that NRG may flex the activities down to help guard cash.
Despite these assumptions, and using the current natural gas forward price curve (NGA <CMDTY> <GO> CCRV <00>), we expect
gross recourse debt leverage would increase from 4.2x to 5.3x at the end of 2013, before falling to 4.3x at the end of 2014. We believe
NRG Energy is set up to survive an extended period of low power prices.
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
ue, 14th Floor, New York, NY 10022
(W)
(F)
NMLS ICA' 853441
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://wwwjpmorgan.corn/pages/disclosures/email.
EFTA00708817
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
gmail.comURL
http://wwwjpmorgan.corn/pages/disclosures/emailWire Ref
refinanceRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.